Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Core Viewpoint - Wall Street analysts anticipate Labcorp (LH) will report quarterly earnings of $3.49 per share, reflecting a year-over-year increase of 3.3%, with revenues expected to reach $3.26 billion, up 6.7% from the previous year [1] Group 1: Earnings and Revenue Estimates - The consensus EPS estimate has been revised 0.8% lower over the last 30 days, indicating a reevaluation of initial estimates by analysts [1] - Analysts forecast 'Revenues- Diagnostics Laboratories' to reach $2.53 billion, representing a 7.9% increase from the year-ago quarter [2] - 'Revenues- Biopharma Laboratory Services' are projected to be $734.73 million, indicating a 2.2% increase from the previous year [2] Group 2: Operating Income Estimates - 'Adjusted Operating Income- Biopharma Laboratory Services' is expected to be $111.44 million, compared to $109 million from the year-ago period [2] - 'Adjusted Operating Income- Diagnostics Laboratories' is projected to be $409.56 million, up from $386.30 million year-over-year [3] Group 3: Stock Performance - Over the past month, Labcorp shares have declined by 2.9%, while the Zacks S&P 500 composite has increased by 4.5% [3] - Labcorp holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the near term [3]